| 1 (166) | AstraZeneca, United Kingdom | GBR |  |
| 2 (177) | GlaxoSmithKline, United Kingdom | GBR | |
| 3 (195) | Bayer AG, Germany | DEU | |
| 4 (209) | AstraZeneca, Sweden | SWE | |
| 5 (249) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 6 (256) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 7 (282) | Merck KGaA, Germany | DEU | |
| 8 (326) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 9 (348) | Janssen Research & Development, LLC | BEL | |
| 10 (369) | Boehringer Ingelheim GmbH Germany | DEU | |
| 11 (393) | Novartis, Switzerland | CHE | |
| 12 (399) | GlaxoSmithKline, Belgium | BEL | |
| 13 (447) | Novo Nordisk A/S | DNK | |
| 14 (501) | Unilever, United Kingdom | GBR | |
| 15 (550) | BASF, Germany | DEU | |
| 16 (558) | Pfizer Inc, United Kingdom | GBR | |
| 17 (560) | Sanofi, Germany | DEU | |
| 18 (561) | UCB Pharma SA, Brussels | BEL | |
| 19 (731) | Syngenta, United Kingdom | GBR | |
|
